Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Zefei Jiang | Researchclopedia

Back to researchers

Zefei Jiang

Qingdao University ORCID

376

Works

15,557

Citations

46

h-index

115

i10-index

Research Topics

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Breast Cancer Treatment Studies

Affiliations

National Natural Science Foundation of China2008–2008

Qingdao University2019–2026

Hebei Medical University2018–2022

Fox Chase Cancer Center2009–2009

BC Cancer Agency2016–2016

Top Works

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Aron Goldhirsch,Eric P. Winer,et al.

20133,674 citations

Cancer Treatment and Pharmacology

Cancer Genomics and Diagnostics

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Alan S. Coates,Eric P. Winer,et al.

20151,821 citations

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano,Harold J. Burstein,et al.

20171,245 citations

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

Harold J. Burstein,Giuseppe Curigliano,et al.

2021773 citations

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

José Baselga,Seock‐Ah Im,et al.

2017535 citations

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Harold J. Burstein,Yan Sun,et al.

2010525 citations

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Nadia Harbeck,Priya Rastogi,et al.

2021370 citations

Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study

Fei Ma,Quchang Ouyang,et al.

2019339 citations

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

Sara A. Hurvitz,Fabrice André,et al.

2015301 citations